|
1
|
Freedman ND, Leitzmann MF, Hollenbeck AR,
Schatzkin A and Abnet CC: Cigarette smoking and subsequent risk of
lung cancer in men and women: Analysis of a prospective cohort
study. Lancet Oncol. 9:649–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Islami F, Torre LA and Jemal A: Global
trends of lung cancer mortality and smoking prevalence. Transl Lung
Cancer Res. 4:327–338. 2015.PubMed/NCBI
|
|
3
|
Xu D, Penning TM, Blair IA and Harvey RG:
Synthesis of phenol and quinone metabolites of
benzo[a]pyrene, a carcinogenic component of tobacco smoke
implicated in lung cancer. J Org Chem. 74:597–604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalabus JL, Cheng Q, Jamil RG, Schuetz EG
and Blanco JG: Induction of carbonyl reductase 1 (CBR1)
expression in human lung tissues and lung cancer cells by the
cigarette smoke constituent benzo[a]pyrene. Toxicol Lett.
211:266–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kasala ER, Bodduluru LN, Barua CC, Sriram
CS and Gogoi R: Benzo(a)pyrene induced lung cancer: Role of dietary
phytochemicals in chemoprevention. Pharmacol Rep. 67:996–1009.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kometani T, Yoshino I, Miura N, Okazaki H,
Ohba T, Takenaka T, Shoji F, Yano T and Maehara Y: Benzo[a]pyrene
promotes proliferation of human lung cancer cells by accelerating
the epidermal growth factor receptor signaling pathway. Cancer
Lett. 278:27–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shinmura K, Iwaizumi M, Igarashi H, Nagura
K, Yamada H, Suzuki M, Fukasawa K and Sugimura H: Induction of
centrosome amplification and chromosome instability in
p53-deficient lung cancer cells exposed to benzo[a]pyrene
diol epoxide (B[a]PDE). J Pathol. 216:365–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang SC, Sheu GT, Wong RH, Huang CY, Weng
MW, Lee LW, Hsu CP and Ko JL: Expression of glutathione
S-transferase M2 in stage I/II non-small cell lung cancer and
alleviation of DNA damage exposure to benzo[a]pyrene. Toxicol Lett.
192:316–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang BY, Wu SY, Tang SC, Lai CH, Ou CC, Wu
MF, Hsiao YM and Ko JL: Benzo[a]pyrene-induced cell cycle
progression occurs via ERK-induced Chk1 pathway activation in human
lung cancer cells. Mutat Res. 773:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoshino I, Kometani T, Shoji F, Osoegawa
A, Ohba T, Kouso H, Takenaka T, Yohena T and Maehara Y: Induction
of epithelial-mesenchymal transition-related genes by
benzo[a]pyrene in lung cancer cells. Cancer. 110:369–374. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dasari V, Gallup M, Lemjabbar H, Maltseva
I and McNamara N: Epithelial-mesenchymal transition in lung cancer:
Is tobacco the ‘smoking gun’? Am J Respir Cell Mol Biol. 35:3–9.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nurwidya F, Takahashi F, Murakami A and
Takahashi K: Epithelial mesenchymal transition in drug resistance
and metastasis of lung cancer. Cancer Res Treat. 44:151–156. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reka AK, Chen G, Jones RC, Amunugama R,
Kim S, Karnovsky A, Standiford TJ, Beer DG, Omenn GS and Keshamouni
VG: Epithelial-mesenchymal transition-associated secretory
phenotype predicts survival in lung cancer patients.
Carcinogenesis. 35:1292–1300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin Q, Xu Y, He T, Qin C and Xu J: Normal
and disease-related biological functions of Twist1 and underlying
molecular mechanisms. Cell Res. 22:90–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han Z, Liu L, Liu Y and Li S: Sirtuin
SIRT6 suppresses cell proliferation through inhibition of Twist1
expression in non-small cell lung cancer. Int J Clin Exp Pathol.
7:4774–4781. 2014.PubMed/NCBI
|
|
18
|
Sakamoto A, Akiyama Y, Shimada S, Zhu WG,
Yuasa Y and Tanaka S: DNA methylation in the exon 1 region and
complex regulation of Twist1 expression in gastric cancer cells.
PLoS One. 10:e01456302015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Qin L, Sun T, Wu H, He T, Yang Z, Mo
Q, Liao L and Xu J: Twist1 promotes breast cancer invasion and
metastasis by silencing Foxa1 expression. Oncogene. 36:1157–1166.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galván JA, Helbling M, Koelzer VH, Tschan
MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H,
Inderbitzin D, et al: TWIST1 and TWIST2 promoter methylation and
protein expression in tumor stroma influence the
epithelial-mesenchymal transition-like tumor budding phenotype in
colorectal cancer. Oncotarget. 6:874–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bing L, Hong C, Li-Xin S and Wei G:
MicroRNA-543 suppresses endometrial cancer oncogenicity via
targeting FAK and TWIST1 expression. Arch Gynecol Obstet.
290:533–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho KH, Jeong KJ, Shin SC, Kang J, Park CG
and Lee HY: STAT3 mediates TGF-β1-induced TWIST1 expression and
prostate cancer invasion. Cancer Lett. 336:167–173. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Angelo RC, Liu XW, Najy AJ, Jung YS, Won
J, Chai KX, Fridman R and Kim HR: TIMP-1 via TWIST1 induces EMT
phenotypes in human breast epithelial cells. Mol Cancer Res.
12:1324–1333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoon NA, Jo HG, Lee UH, Park JH, Yoon JE,
Ryu J, Kang SS, Min YJ, Ju SA, Seo EH, et al: Tristetraprolin
suppresses the EMT through the down-regulation of Twist1 and Snail1
in cancer cells. Oncotarget. 7:8931–8943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li L and Wu D: miR-32 inhibits
proliferation, epithelial-mesenchymal transition, and metastasis by
targeting TWIST1 in non-small-cell lung cancer cells. Onco Targets
Ther. 9:1489–1498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burns TF, Dobromilskaya I, Murphy SC,
Gajula RP, Thiyagarajan S, Chatley SN, Aziz K, Cho YJ, Tran PT and
Rudin CM: Inhibition of TWIST1 leads to activation of
oncogene-induced senescence in oncogene-driven non-small cell lung
cancer. Mol Cancer Res. 11:329–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Zhai W, Wang H, Xia X and Zhang C:
Benzo(a)pyrene promotes A549 cell migration and invasion through
up-regulating Twist. Arch Toxicol. 89:451–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hänze J, Henrici M, Hegele A, Hofmann R
and Olbert PJ: Epithelial mesenchymal transition status is
associated with anti-cancer responses towards receptor
tyrosine-kinase inhibition by dovitinib in human bladder cancer
cells. BMC Cancer. 13:5892013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li B, Zheng YW, Sano Y and Taniguchi H:
Evidence for mesenchymal-epithelial transition associated with
mouse hepatic stem cell differentiation. PLoS One. 6:e170922011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shirakihara T, Saitoh M and Miyazono K:
Differential regulation of epithelial and mesenchymal markers by
deltaEF1 proteins in epithelial mesenchymal transition induced by
TGF-beta. Mol Biol Cell. 18:3533–3544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen SF, Nieh S, Jao SW, Wu MZ, Liu CL,
Chang YC and Lin YS: The paracrine effect of cancer-associated
fibroblast-induced interleukin-33 regulates the invasiveness of
head and neck squamous cell carcinoma. J Pathol. 231:180–189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng J, Fu Z, Guo J, Lu W, Wen K, Chen W,
Wang H, Wei J and Zhang S: Overexpression of peroxiredoxin 2
inhibits TGF-β1-induced epithelial-mesenchymal transition and cell
migration in colorectal cancer. Mol Med Rep. 10:867–873. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee YJ, Han ME, Baek SJ, Kim SY and Oh SO:
MED30 regulates the proliferation and motility of gastric cancer
Cells. PLoS One. 10:e01308262015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gort EH, van Haaften G, Verlaan I, Groot
AJ, Plasterk RH, Shvarts A, Suijkerbuijk KP, van Laar T, van der
Wall E, Raman V, et al: The TWIST1 oncogene is a direct
target of hypoxia-inducible factor-2alpha. Oncogene. 27:1501–1510.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Laursen KB, Mielke E, Iannaccone P and
Füchtbauer EM: Mechanism of transcriptional activation by the
proto-oncogene Twist1. J Biol Chem. 282:34623–34633. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nairismägi ML, Füchtbauer A, Labouriau R,
Bramsen JB and Füchtbauer EM: The proto-oncogene TWIST1 is
regulated by microRNAs. PLoS One. 8:e660702013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen H, Hu L, Luo Z, Zhang J, Zhang C, Qiu
B, Dong L, Tan Y, Ding J, Tang S, et al: A20 suppresses
hepatocellular carcinoma proliferation and metastasis through
inhibition of Twist1 expression. Mol Cancer. 14:1862015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qian J, Luo Y, Gu X, Zhan W and Wang X:
Twist1 promotes gastric cancer cell proliferation through
up-regulation of FoxM1. PLoS One. 8:e776252013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qiang L, Zhao B, Ming M, Wang N, He TC,
Hwang S, Thorburn A and He YY: Regulation of cell proliferation and
migration by p62 through stabilization of Twist1. Proc Natl Acad
Sci USA. 111:9241–9246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Orlandella FM, Di Maro G, Ugolini C,
Basolo F and Salvatore G: TWIST1/miR-584/TUSC2
pathway induces resistance to apoptosis in thyroid cancer cells.
Oncotarget. 7:70575–70588. 2016.PubMed/NCBI
|
|
43
|
Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X
and Zou Q: TWIST1 and BMI1 in cancer metastasis and
chemoresistance. J Cancer. 7:1074–1080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
da Silva SD, Alaoui-Jamali MA, Soares FA,
Carraro DM, Brentani HP, Hier M, Rogatto SR and Kowalski LP: TWIST1
is a molecular marker for a poor prognosis in oral cancer and
represents a potential therapeutic target. Cancer. 120:352–362.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tran PT, Shroff EH, Burns TF, Thiyagarajan
S, Das ST, Zabuawala T, Chen J, Cho YJ, Luong R, Tamayo P, et al:
Twist1 suppresses senescence programs and thereby
accelerates and maintains mutant Kras-induced lung
tumorigenesis. PLoS Genet. 8:e10026502012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
